• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Highlights of India’s first Biotech startup Expo
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid
  • Moderna and Pfizer: Lawsuits and Charitable Giving
  • European Commission Approves Two GM Crops for Food and Feed
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande

Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande

0
By Biotech Express on May 15, 2022 Articles, Articles- Guestorials
The peer review system – or the evaluation of academic work by others in the same field – has broken down because authors can just pay to be published, says leading biologist Shekhar Mande.

The former director general of the Council of Scientific and Industrial Research (CSIR) told ThePrint that mushrooming online journals, even the reputed ones, charge an author hefty fees to post their scientific findings. Mande said a scientific publication brought in only a very small set of editors and peer reviewers to vet this article. This introduced a lot of subjectivity and personal bias in the system, he said.

Mande spoke of the art of peer-reviewing in olden times. “Traditionally, the way knowledge advanced was that learned people got together, debated the known current facts… if someone proposed advanced material, this too was debated in a fraternity of very well-known people.”

He said noted examples of such peer reviews in ancient India took place at Nalanda and Takshashila universities, where learned people gathered to debate whether to accept a new discovery. But in the last 100 years, the focus has been on printing scientific research, Mande said. He added: “A person who has discovered something new, now wants to announce it to the public by sending a written article to a journal.”

“The journal has either one or a set of editors… out of which, one editor would take a decision on this. And it would be reviewed by two or three peers. “So what used to be debates among many learned people, is now reduced to opinions of only one or two people. And as we know, human opinions are always subjective.”

Mande said when such new thoughts came from a country like India, or lesser known countries, the West tended not to accept them. “So in that sense, the peer review system is broken,” he said.

Mande emphasised that a “complete breakdown” has taken place only recently – due to the surge in online publishing and “author-pays” model. He took the example of an infamous paper that claimed the antimalarial drug hydroxychloroquine could help treat Covid. It was published and later retracted by The Lancet journal.
Mande said: “That particular paper would not have passed a peer-to-peer review system in any other journal. But what were the arguments for accepting it by a journal like The Lancet? We don’t know.”

He added that many well-reputed journals in the world today were continuously retracting papers which have been published in the past, because they were not appropriately reviewed. Mande has recently published this view in an article in Current Science.

‘Study science if you are a dreamer’

Mande said science was for dreamers and those who wanted to contribute fresh thoughts to knowledge. He said: “You are best fitted to scientific work if you are driven by the passion of contributing new thoughts to the world.”

When he took over as director general of CSIR in 2018, Mande said the morals of scientists needed a boost. “Moreover, the connection with industry has been diminishing,” he said, adding that he has focused on rejuvenating this relationship. “An important component of science is continuous advance into new territory. Another is that while doing so, we translate it for the benefit of people,” Mande said.

He added: “That’s a very, very important aspect of science. When scientists receive financial support from the public, expectations are that scientific discoveries would eventually turn into technologies that would benefit people.”

Is all ok with CSIR stipends?

The scientist also addressed reports that PhD students at CSIR institutions were not receiving fellowships for months on end. He said: “It was a matter of great embarrassment to me when I was director general that the fellowships were not being disbursed on time to many students.”

He said the various processes that involved collecting attendance certificates added to the delay in monthly stipends, but a lot of the delays also happened when students switched universities.

“But the work has now begun on war-footing to resolve such cases. I expect most of them will be done by September or October,” he added.

Note: Article First published on The Print on 15 May, 2022, Source: https://theprint.in/india/paid-publishing-in-science-has-killed-peer-review-system-says-csirs-ex-chief-shekhar-mande/952841/

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible?

Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha

Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports

Leave A Reply Cancel Reply

Current Issue – May 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
  • Moderna and Pfizer: Lawsuits and Charitable Giving May 25, 2022
  • European Commission Approves Two GM Crops for Food and Feed May 25, 2022
  • Ayush Ministry, DBT sign MoU for cooperation on evidence-based biotech interventions in Ayush sector May 24, 2022
  • CCI, India merger approved absorption of Covidshield Technologies into Biocon Biologics May 20, 2022
  • No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible? May 19, 2022
  • Industry lobbying on WHO overshadowing public health policy, researchers suggest May 18, 2022
  • Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha May 15, 2022
  • Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande May 15, 2022
  • Bill Gates tests positive for COVID-19 even after many booster doses, mocked on twitter May 10, 2022
  • Another Ivermectin COVID-19 paper retracted May 8, 2022
  • COVID-19 spike protein paper retracted May 7, 2022
  • Killer Music? Can sound make a clot in a boy who died while dancing or it is related to COVID vaccination May 7, 2022
  • Clotting Risks Cause FDA to Restrict Use of J&J COVID Vaccine May 6, 2022
  • Department of Pharmaceuticals releases “Common Guidelines on Pharmaceutical Innovation and Entrepreneurship” for academic institutions May 6, 2022
  • No medical care for 45% of recorded deaths in 2020, highest ever in India: New data May 6, 2022
  • Indian opposition seeks higher compensation for COVID deaths after damning WHO report May 6, 2022
  • Redcliffe Lifetech raises $61 million in Series B funding May 6, 2022
  • Engineers Create an Enzyme That Breaks Down Plastic Waste in Hours, Not Decades May 5, 2022
  • Eris Lifesciences acquires 100% stake in Oaknet Healthcare for Rs 650 cr May 5, 2022
  • The Union Government has Lied to the Supreme Court in COVID Vaccines Case? May 5, 2022
  • COVID-19- vitamin D paper from India retracted by Springer Nature journal May 4, 2022
  • IISc develops 3D printed gloves for rehabilitating stroke patients May 4, 2022
  • A new wearable technology — for plants May 4, 2022
  • Sanofi India names Rodolfo Hrosz managing director effective June 1 May 4, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.